Tenaya Therapeutics (TNYA) Shares Outstanding (Weighted Average) (2020 - 2026)

Tenaya Therapeutics has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $216.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 97.4% year-over-year to $216.9 million; the trailing twelve-month figure through Mar 2026 stood at $216.9 million (up 97.4% YoY), and the FY2025 full-year result was $153.0 million, up 80.34% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $216.9 million, up from $153.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $216.9 million in Q1 2026, with the low at $41.3 million in Q1 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $92.8 million, with a median of $81.0 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) surged 3659.14% in 2022 and gained 10.79% in 2024.
• Tracing TNYA's Shares Outstanding (Weighted Average) over 5 years: stood at $44.8 million in 2022, then jumped by 64.61% to $73.8 million in 2023, then climbed by 14.96% to $84.8 million in 2024, then surged by 80.34% to $153.0 million in 2025, then jumped by 41.78% to $216.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $216.9 million (Q1 2026), $153.0 million (Q4 2025), and $163.3 million (Q3 2025), per Business Quant data.

Peer Comparison